Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Actuate Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Institut Bergonié
M.D. Anderson Cancer Center
GI Innovation, Inc.
Federation Francophone de Cancerologie Digestive
ImmunityBio, Inc.
ImmunityBio, Inc.
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
The Netherlands Cancer Institute
The Netherlands Cancer Institute
American College of Radiology Imaging Network
Eli Lilly and Company
AGC Biologics S.p.A.
M.D. Anderson Cancer Center
AGC Biologics S.p.A.
Region Skane
Yale University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
Centro Nacional de Investigaciones Oncologicas CARLOS III
Catharina Ziekenhuis Eindhoven
Catharina Ziekenhuis Eindhoven
Bristol-Myers Squibb
Amgen
University of Kentucky
Case Comprehensive Cancer Center
Alaunos Therapeutics
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)